Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Conversion of 61,342 IAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Iambic Therapeutics, Inc. (IAM) | Conversion | 61,342 | n/a |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | Grant/Award | 28,400 | n/a |
| Nov 19, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 11,937 | $73.7K |
| Nov 15, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |
| Oct 10, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |
| Sep 12, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |
| Aug 19, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 11,962 | $80.0K |
| Aug 15, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |
| Jul 11, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |
| Jun 17, 2024 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 39,375 | $87.4K |